This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gabr, A. Articles by Smets, L. A. Search for Related Content PubMed PubMed Citation Articles by Gabr, A. Articles by Smets, L. A.

Cellular Pharmacokinetics and Cytotoxicity of Camptothecin and Topotecan at Normal and Acidic pH¹

Division of Experimental Therapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis, Amsterdam, the Netherlands [A. G., A. K., M. A., L. A. S.], and the Department of Pharmacology, Faculty of Medicine, Suez Canal University, Ismalia, Egypt [H. E-G.]

pH-mediated conversions in the structure of the topoisomerase (topo) I inhibitors camptothecin (CPT) and its analogues have strong implications for the pharmacokinetics and pharmacodynamics of these novel anticancer agents. Because the cell-penetrating and biologically active lactone isomers predominate at acidic conditions, we have tested if low pH potentiates the cytotoxic and antitumor effects of CPT and its water-soluble derivative topotecan (TPT). In L1210 leukemia cells, rapid initial uptake of radiolabeled CPT and TPT was followed by a gradual release from cells at physiological pH 7.4, whereas high drug levels were maintained in cells at pH 6.2. Steady-state uptake levels of CPT increased proportionally, up to 5-fold, with decreasing pH of the incubating medium (from 7.4 to 6.0). With TPT, a maximum 3-fold increase was observed at pH 6.8 to 6.4. By contrast, the cellular pharmacokinetics of the topoisomerase II inhibitor etoposide (ETP) were independent of the ambient pH. The large increases in intracellular CPT and TPT levels caused only moderate potentiation of cytotoxicity in short-term incubations. Conditions of very low pH 6.2 even antagonized the cytotoxicity of the topo I and topo II inhibitors, due to inhibition of DNA synthesis by intracellular acidification. However, in clinically relevant schedules of prolonged exposures at low drug concentration, low pH potentiated the cytotoxicity of CPT and TPT by 2-3-fold. To investigate the effect of local pH in vivo, the basal interstitial pH of 6.8 of RIF-1 tumors was selectively lowered by i.p. injection of the host animals with the mitochondrial inhibitor meta-iodobenzylguanidine (32 mg/kg) and glucose (1.5 g/kg). In accordance with the pH optimum for TPT uptake at pH 6.8 to 6.4, tumor acidification had no effect on the antitumor effect of this analogue. By contrast, the intervention significantly potentiated the response of tumors to CPT. The results indicate that local pH is an important determinant of the cellular pharmacokinetics and the antitumor activity of CPT and analogues.

¹ Supported by Grant NKI 91-14 of the Dutch Cancer Society (to L. A. S.). A. G. was the recipient of a fellowship from the Channel System of the Egyptian Ministry of Education.

² Present address: Department of Pharmacology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

³ To whom requests for reprints should be addressed, at The Netherlands Cancer Institute, 121 Plesmanlaan, 1066 CX, Amsterdam, the Netherlands. Phone: 31 20 5122041; Fax: 31 20 5122050.

Received 4/21/97. Accepted 8/28/97.

This article has been cited by other articles:

				F. An, D. C. Drummond, S. Wilson, D. B. Kirpotin, S. L. Nishimura, V. C. Broaddus, and B. Liu Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies Mol. Cancer Ther., March 1, 2008; 7(3): 569 - 578. [Abstract] [Full Text] [PDF]

				A. Roth, D. C. Drummond, F. Conrad, M. E. Hayes, D. B. Kirpotin, C. C. Benz, J. D. Marks, and B. Liu Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells Mol. Cancer Ther., October 1, 2007; 6(10): 2737 - 2746. [Abstract] [Full Text] [PDF]

				P. Breedveld, D. Pluim, G. Cipriani, F. Dahlhaus, M. A. J. van Eijndhoven, C. J. F. de Wolf, A. Kuil, J. H. Beijnen, G. L. Scheffer, G. Jansen, et al. The Effect of Low pH on Breast Cancer Resistance Protein (ABCG2)-Mediated Transport of Methotrexate, 7-Hydroxymethotrexate, Methotrexate Diglutamate, Folic Acid, Mitoxantrone, Topotecan, and Resveratrol in In Vitro Drug Transport Models Mol. Pharmacol., January 1, 2007; 71(1): 240 - 249. [Abstract] [Full Text] [PDF]

				L. E. Gerweck, S. Vijayappa, and S. Kozin Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics Mol. Cancer Ther., May 1, 2006; 5(5): 1275 - 1279. [Abstract] [Full Text] [PDF]

				F. MUGGIA, L. LIEBES, M. POTMESIL, A. HAMILTON, H. HOCHSTER, G. HORNREICH, J. SORICH, A. DOWNEY, and H. WASSERSTROM Intraperitoneal Topoisomerase-I Inhibitors: Preliminary Findings with 9-Aminocamptothecin Ann. N.Y. Acad. Sci., December 1, 2000; 922(1): 178 - 187. [Abstract] [Full Text] [PDF]

				C. F. VERSCHRAEGEN, K. JAECKLE, B. GIOVANELLA, V. KNIGHT, and B. E. GILBERT Alternative Administration of Camptothecin Analogues Ann. N.Y. Acad. Sci., December 1, 2000; 922(1): 237 - 246. [Abstract] [Full Text] [PDF]

				H. J. Lim, M. J. Parr, D. Masin, N. L. McIntosh, T. D. Madden, G. Zhang, S. Johnstone, and M. B. Bally Kupffer Cells Do Not Play a Role in Governing the Efficacy of Liposomal Mitoxantrone Used to Treat a Tumor Model Designed to Assess Drug Delivery to Liver Clin. Cancer Res., November 1, 2000; 6(11): 4449 - 4460. [Abstract] [Full Text] [PDF]

				S. Okuno, M. Harada, T. Yano, S. Yano, S. Kiuchi, N. Tsuda, Y. Sakamura, J. Imai, T. Kawaguchi, and K. Tsujihara Complete Regression of Xenografted Human Carcinomas by Camptothecin Analogue-Carboxymethyl Dextran Conjugate (T-0128) Cancer Res., June 1, 2000; 60(11): 2988 - 2995. [Abstract] [Full Text] [PDF]

				D. M. Prescott, H. C. Charles, J. M. Poulson, R. L. Page, D. E. Thrall, Z. Vujaskovic, and M. W. Dewhirst The Relationship between Intracellular and Extracellular pH in Spontaneous Canine Tumors Clin. Cancer Res., June 1, 2000; 6(6): 2501 - 2505. [Abstract] [Full Text]